Failure of Manganese to Protect from Shiga Toxin

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Gaston, Marsha A ^a   Pellino, Christine A ^a   Weiss, Alison A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MANGANESE CHLORIDE; VEROTOXIN 1; VEROTOXIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG EFFICACY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; TOXICITY TESTING; VERO CELL;

ANIMALS; CERCOPITHECUS AETHIOPS; ESCHERICHIA COLI INFECTIONS; MALE; MANGANESE; MICE; SHIGA TOXIN; SHIGA-TOXIGENIC ESCHERICHIA COLI; VERO CELLS;

EID: 84880458947     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069823     Document Type: Article

References (33)

1. Tarr PI, Gordon CA, Chandler WL, (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073-1086.
2. Fuller CA, Pellino CA, Flagler MJ, Strasser JE, Weiss AA, (2011) Shiga toxin subtypes display dramatic differences in potency. Infect Immun 79: 1329-1337.
3. Tesh VL, Burris JA, Owens JW, Gordon VM, Wadolkowski EA, et al. (1993) Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61: 3392-3402.
4. Siegler RL, Obrig TG, Pysher TJ, Tesh VL, Denkers ND, et al. (2003) Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol 18: 92-96.
5. Stearns-Kurosawa DJ, Collins V, Freeman S, Tesh VL, Kurosawa S, (2010) Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli. Infect Immun 78: 2497-2504.
6. Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, et al. (1999) Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37: 497-503.
7. Sandvig K, Brown JE, (1987) Ionic requirements for entry of Shiga toxin from Shigella dysenteriae 1 into cells. Infect Immun 55: 298-303.
8. Mukhopadhyay S, Linstedt AD, (2012) Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis. Science 335: 332-335.
9. Sandvig K, van Deurs B, (2000) Entry of ricin and Shiga toxin into cells: Molecular mechanisms and medical perspectives. EMBO J 19: 5943-5950.
10. Torgersen ML, Engedal N, Bergan J, Sandvig K, (2010) The intracellular journey of Shiga toxins. The Open Toxinology Journal 3: 3-12.
11. Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, et al. (1988) Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 171: 45-50.
12. McKenzie J, Johannes L, Taguchi T, Sheff D, (2009) Passage through the Golgi is necessary for Shiga toxin B subunit to reach the endoplasmic reticulum. FEBS J 276: 1581-1595.
13. McGannon CM, Fuller CA, Weiss AA, (2010) Different classes of antibiotics differentially influence Shiga toxin production. Antimicrob Agents Chemother 54: 3790-3798.
14. Pudymaitis A, Lingwood CA, (1992) Susceptibility to verotoxin as a function of the cell cycle. J Cell Physiol 150: 632-639.
15. Betz J, Bielaszewska M, Thies A, Humpf HU, Dreisewerd K, et al. (2011) Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: Differential association with membrane lipid raft microdomains. J Lipid Res 52: 618-634.
16. Obata F, Tohyama K, Bonev AD, Kolling GL, Keepers TR, et al. (2008) Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. J Infect Dis 198: 1398-1406.
17. Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L, et al. (1993) Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 268: 15484-15488.
18. Engedal N, Skotland T, Torgersen ML, Sandvig K, (2011) Shiga toxin and its use in targeted cancer therapy and imaging. Microb Biotechnol 4: 32-46.
19. Sandvig K (2005) The Shiga toxins: Properties and action on cells. In: Alouf JE, Popoff MR, editors. The Comprehensive Sourcebook of Bacterial Protein Toxins.: Academic Press. 310-322.
20. Papp-Wallace KM, Maguire ME, (2006) Manganese transport and the role of manganese in virulence. Annu Rev Microbiol 60: 187-209.
21. Borgstahl GE, Parge HE, Hickey MJ, Beyer WF Jr, Hallewell RA, et al. (1992) The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles. Cell 71: 107-118.
22. Kanyo ZF, Scolnick LR, Ash DE, Christianson DW, (1996) Structure of a unique binuclear manganese cluster in arginase. Nature 383: 554-557.
23. Besio R, Baratto MC, Gioia R, Monzani E, Nicolis S,et al. (2012) A Mn(II)-Mn(II) center in human prolidase. Biochim Biophys Acta.
24. Hudnell HK, (1999) Effects from environmental Mn exposures: A review of the evidence from non-occupational exposure studies. Neurotoxicology 20: 379-397.
25. Lauwerys R, Roels H, Genet P, Toussaint G, Bouckaert A, et al. (1985) Fertility of male workers exposed to mercury vapor or to manganese dust: A questionnaire study. Am J Ind Med 7: 171-176.
26. Ponnapakkam TP, Bailey KS, Graves KA, Iszard MB, (2003) Assessment of male reproductive system in the CD-1 mice following oral manganese exposure. Reprod Toxicol 17: 547-551.
27. Wirth JJ, Rossano MG, Daly DC, Paneth N, Puscheck E, et al. (2007) Ambient manganese exposure is negatively associated with human sperm motility and concentration. Epidemiology 18: 270-273.
28. Treinen KA, Gray TJ, Blazak WF, (1995) Developmental toxicity of mangafodipir trisodium and manganese chloride in Sprague-Dawley rats. Teratology 52: 109-115.
29. Colomina MT, Domingo JL, Llobet JM, Corbella J, (1996) Effect of day of exposure on the developmental toxicity of manganese in mice. Vet Hum Toxicol 38: 7-9.
30. Crossgrove J, Zheng W, (2004) Manganese toxicity upon overexposure. NMR Biomed 17: 544-553.
31. Symonds HW, Hall ED, (1983) Acute manganese toxicity and the absorption and biliary excretion of manganese in cattle. Res Vet Sci 35: 5-13.
32. [Anonymous] (1996) Chronic health hazard assessments for noncarcinogenic effects, Reference dose for chronic oral exposure (RfD). In: Anonymous Integrated Risk Information System, Manganese (CASRN 7439-96-5).
33. World Health Organization (1999) Manganese and its compounds. concise international chemical assessment document 12.